BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36880167)

  • 21. Prognostic implication of tumor spread through air spaces in patients with pathologic N0 lung adenocarcinoma.
    Chen S; Ye T; Yang S; Zhao Y; Zhang Y; Huang Q; Wu H; Hu H; Sun Y; Zhang Y; Xiang J; Wang S; Gu Y; Jin Y; Li Y; Chen H
    Lung Cancer; 2022 Feb; 164():33-38. PubMed ID: 34974223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer.
    Mei SQ; Liu JQ; Huang ZJ; Luo WC; Peng YL; Chen ZH; Deng Y; Xu CR; Zhou Q
    Thorac Cancer; 2024 May; 15(14):1119-1131. PubMed ID: 38558529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
    Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
    Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.
    Fukuhara M; Muto S; Inomata S; Yamaguchi H; Mine H; Takagi H; Ozaki Y; Watanabe M; Inoue T; Yamaura T; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Shio Y; Suzuki H
    Cancer Immunol Immunother; 2022 May; 71(5):1129-1137. PubMed ID: 34596720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
    Tanaka T; Masuda A; Inoue J; Hamada T; Ikegawa T; Toyama H; Sofue K; Shiomi H; Sakai A; Kobayashi T; Tanaka S; Nakano R; Yamada Y; Ashina S; Tsujimae M; Yamakawa K; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Kanzawa M; Itoh T; Ueda Y; Fukumoto T; Kodama Y
    J Gastroenterol; 2023 Mar; 58(3):277-291. PubMed ID: 36705749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer.
    Wang L; Gong S; Pang L; Zhang S; Zhang X; He W
    Sci Rep; 2023 Aug; 13(1):13542. PubMed ID: 37598257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
    Yazaki S; Shimoi T; Yoshida M; Sumiyoshi-Okuma H; Arakaki M; Saito A; Kita S; Yamamoto K; Kojima Y; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Murata T; Shiino S; Takayama S; Suto A; Ohe Y; Fujiwara Y; Yonemori K
    Breast Cancer Res Treat; 2023 Jan; 197(2):287-297. PubMed ID: 36385236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective.
    Jia W; Yao Q; Wang Y; Mao Z; Zhang T; Li J; Nie Y; Lei X; Shi W; Song W
    Front Immunol; 2022; 13():1007426. PubMed ID: 36189217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
    An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
    Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure.
    Liu W; You W; Lan Z; Ren Y; Gao S; Li S; Chen WW; Huang C; Zeng Y; Xiao N; Wang Z; Xie H; Ma H; Chen Y; Wang G; Chen C; Li H
    Cell Rep Med; 2024 Mar; 5(3):101448. PubMed ID: 38458196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patients with tumor spread through air spaces.
    Lv Y; Li S; Liu Z; Ren Z; Zhao J; Tao G; Zheng Z; Han Y; Ye B
    Lung Cancer; 2023 Mar; 177():51-58. PubMed ID: 36736075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies.
    Peng H; Wu X; Zhang C; Liang Y; Cheng S; Zhang H; Shen L; Chen Y
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):153. PubMed ID: 38519621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tertiary lymphoid structures in lung adenocarcinoma: characteristics and related factors.
    Ren F; Xie M; Gao J; Wu C; Xu Y; Zang X; Ma X; Deng H; Song J; Huang A; Pang L; Qian J; Yu Z; Zhuang G; Liu S; Pan L; Xue X
    Cancer Med; 2022 Aug; 11(15):2969-2977. PubMed ID: 35801360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
    Chen G; Dong Z; Wu D; Chen Y
    J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of immune cell infiltration and prognostic value of tertiary lymphoid structures in gastric cancer.
    Yu JS; Huang WB; Zhang YH; Chen J; Li J; Fu HF; Wei ZW; He YL
    Neoplasma; 2022 Jul; 69(4):886-898. PubMed ID: 35603954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the effect of spread through air spaces on postoperative recurrence-free survival in patients with stage pT1N0M0 lung adenocarcinoma of different tumor size].
    Zeng H; Tan FW; Yuan ZL; Ren JY; Xu JX; Xue Q
    Zhonghua Yi Xue Za Zhi; 2022 May; 102(19):1430-1436. PubMed ID: 35599407
    [No Abstract]   [Full Text] [Related]  

  • 39. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
    Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
    Front Immunol; 2022; 13():950001. PubMed ID: 36091041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III.
    Yanagawa N; Shiono S; Endo M; Ogata SY
    Lung Cancer; 2018 Jun; 120():14-21. PubMed ID: 29748009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.